Literature DB >> 19676101

Effect of dopamine transporter gene (SLC6A3) variation on dorsal anterior cingulate function in attention-deficit/hyperactivity disorder.

Ariel B Brown1,2, Joseph Biederman1, Eve M Valera1,3, Alysa E Doyle1, George Bush3, Thomas Spencer1, Michael C Monuteaux1, Eric Mick1, Susan Whitfield-Gabrieli4, Nikos Makris5,6, Peter S LaViolette1, Marlene Oscar-Berman2,7,8, Stephen V Faraone9, Larry J Seidman1,10.   

Abstract

Although attention-deficit/hyperactivity disorder (ADHD) is associated both with brain alterations in attention and executive function (EF) circuitry and with genetic variations within the dopamine system (including the dopamine transporter gene [SLC6A3]), few studies have directly investigated how genetic variations are linked to brain alterations. We sought to examine how a polymorphism in the 3' untranslated region (UTR) of SLC6A3, associated with ADHD in meta-analysis, might contribute to variation in dorsal anterior cingulate cortex (dACC) function in subjects with ADHD. We collected fMRI scans of 42 individuals with ADHD, all of European descent and over the age of 17, while they performed the multi-source interference task (MSIT), a cognitive task shown to activate dACC. SLC6A3 3' UTR variable number tandem repeat (VNTR) polymorphisms were genotyped and brain activity was compared for groups based on allele status. ADHD individuals homozygous for the 10R allele showed significant hypoactivation in the left dACC compared to 9R-carriers. Exploratory analysis also showed trends toward hypoactivation in the 10R homozygotes in left cerebellar vermis and right lateral prefrontal cortex. Further breakdown of genotype groups showed similar activation in individuals heterozygous and homozygous for the 9R allele. Alterations in activation of attention and EF networks found previously to be involved in ADHD are likely influenced by SLC6A3 genotype. This genotype may contribute to heterogeneity of brain alterations found within ADHD samples. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19676101      PMCID: PMC2915441          DOI: 10.1002/ajmg.b.31022

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  52 in total

1.  Effect of conflicting cues on information processing: the 'Stroop effect' vs. the 'Simon effect'.

Authors:  J R Simon; K Berbaum
Journal:  Acta Psychol (Amst)       Date:  1990-03

Review 2.  The dopamine transporter and attention-deficit/hyperactivity disorder.

Authors:  Bertha K Madras; Gregory M Miller; Alan J Fischman
Journal:  Biol Psychiatry       Date:  2005-01-05       Impact factor: 13.382

3.  Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: a study with functional MRI.

Authors:  K Rubia; S Overmeyer; E Taylor; M Brammer; S C Williams; A Simmons; E T Bullmore
Journal:  Am J Psychiatry       Date:  1999-06       Impact factor: 18.112

4.  Meta-analysis of structural imaging findings in attention-deficit/hyperactivity disorder.

Authors:  Eve M Valera; Stephen V Faraone; Kate E Murray; Larry J Seidman
Journal:  Biol Psychiatry       Date:  2006-09-01       Impact factor: 13.382

5.  Expression of the dopamine transporter gene is regulated by the 3' UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR.

Authors:  Jonathan Mill; Philip Asherson; Clare Browes; Ursula D'Souza; Ian Craig
Journal:  Am J Med Genet       Date:  2002-12-08

6.  Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop.

Authors:  G Bush; J A Frazier; S L Rauch; L J Seidman; P J Whalen; M A Jenike; B R Rosen; J Biederman
Journal:  Biol Psychiatry       Date:  1999-06-15       Impact factor: 13.382

Review 7.  Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder.

Authors:  Michael A van der Kooij; Jeffrey C Glennon
Journal:  Neurosci Biobehav Rev       Date:  2007-01-23       Impact factor: 8.989

8.  The Multi-Source Interference Task: validation study with fMRI in individual subjects.

Authors:  G Bush; L M Shin; J Holmes; B R Rosen; B A Vogt
Journal:  Mol Psychiatry       Date:  2003-01       Impact factor: 15.992

9.  Increased NAA and reduced choline levels in the anterior cingulum following chronic methylphenidate. A spectroscopic test-retest study in adult ADHD.

Authors:  Golo Kronenberg; Gabriele Ende; Barbara Alm; Michael Deuschle; Isabella Heuser; Michael Colla
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-03-11       Impact factor: 5.270

10.  Dopamine transporter genotype conveys familial risk of attention-deficit/hyperactivity disorder through striatal activation.

Authors:  Sarah Durston; John A Fossella; Martijn J Mulder; B J Casey; Tim B Ziermans; M Nathalie Vessaz; Herman VAN Engeland
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-01       Impact factor: 8.829

View more
  19 in total

Review 1.  The use of α-2A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorder.

Authors:  Amy F T Arnsten
Journal:  Expert Rev Neurother       Date:  2010-10       Impact factor: 4.618

2.  Working memory network alterations and associated symptoms in adults with ADHD and Bipolar Disorder.

Authors:  Ariel Brown; Joseph Biederman; Eve Valera; Alexandra Lomedico; Megan Aleardi; Nikos Makris; Larry J Seidman
Journal:  J Psychiatr Res       Date:  2012-01-23       Impact factor: 4.791

3.  Additive effects of the dopamine D2 receptor and dopamine transporter genes on the error-related negativity in young children.

Authors:  A Meyer; D N Klein; D C Torpey; A J Kujawa; E P Hayden; H I Sheikh; S M Singh; G Hajcak
Journal:  Genes Brain Behav       Date:  2012-06-28       Impact factor: 3.449

4.  Relationship of DAT1 and adult ADHD to task-positive and task-negative working memory networks.

Authors:  Ariel Beth Brown; Joseph Biederman; Eve Valera; Nikos Makris; Alysa Doyle; Susan Whitfield-Gabrieli; Eric Mick; Thomas Spencer; Stephen Faraone; Larry Seidman
Journal:  Psychiatry Res       Date:  2011-05-18       Impact factor: 3.222

Review 5.  Cingulate, frontal, and parietal cortical dysfunction in attention-deficit/hyperactivity disorder.

Authors:  George Bush
Journal:  Biol Psychiatry       Date:  2011-04-13       Impact factor: 13.382

6.  Interactions between early parenting and a polymorphism of the child's dopamine transporter gene in predicting future child conduct disorder symptoms.

Authors:  Benjamin B Lahey; Paul J Rathouz; Steve S Lee; Andrea Chronis-Tuscano; William E Pelham; Irwin D Waldman; Edwin H Cook
Journal:  J Abnorm Psychol       Date:  2011-02

7.  Dopamine transporter gene variation modulates activation of striatum in youth with ADHD.

Authors:  Anne-Claude Bédard; Kurt P Schulz; Edwin H Cook; Jin Fan; Suzanne M Clerkin; Iliyan Ivanov; Jeffrey M Halperin; Jeffrey H Newcorn
Journal:  Neuroimage       Date:  2009-12-21       Impact factor: 6.556

Review 8.  Monoamine transporters: vulnerable and vital doorkeepers.

Authors:  Zhicheng Lin; Juan J Canales; Thröstur Björgvinsson; Morgane Thomsen; Hong Qu; Qing-Rong Liu; Gonzalo E Torres; S Barak Caine
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

9.  SLC9A9 mutations, gene expression, and protein-protein interactions in rat models of attention-deficit/hyperactivity disorder.

Authors:  Yanli Zhang-James; Tania DasBanerjee; Terje Sagvolden; Frank A Middleton; Stephen V Faraone
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2011-08-19       Impact factor: 3.568

10.  Functional effects of dopamine transporter gene genotypes on in vivo dopamine transporter functioning: a meta-analysis.

Authors:  S V Faraone; T J Spencer; B K Madras; Y Zhang-James; J Biederman
Journal:  Mol Psychiatry       Date:  2013-09-24       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.